Home » Archive

Xconomy

News, Syndication, Xconomy »

Biotech and Fantasy Football Picks for Fall 2013

Posted by sandiegobiotech September 3rd, 2013 .
No Comments

There’s an old saying about surgeons. They are “sometimes wrong; never in doubt.” If only the same could be said for biotech writers. I’ve been sometimes right, sometimes wrong, and sometimes…

[[Click headline to continue reading.]]

More...

Events, News, Syndication, Xconomy »

Announcing Oct. 15 Xconomy Healthcare Summit: Request An Invitation

Posted by sandiegobiotech August 28th, 2013 .
No Comments

There’s hardly an issue that is more of a hot button than healthcare—and there’s hardly an issue that is surrounded by as much poorly understood, misguided, or outright misleading information. Yet…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Why Good Drugs Sometimes Fail: The Bexxar Story

Posted by sandiegobiotech August 26th, 2013 .
No Comments

Quite a few biotech entrepreneurs go to work each day operating under the assumption that clinical trial data is king. If you put together a rock-solid dataset from a big clinical trial that says…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Applied Proteomics Snags $28M to Look for Disease Markers in Blood

Posted by sandiegobiotech August 21st, 2013 .
No Comments

San Diego’s Applied Proteomics, founded in 2007 to automate the process of accurately measuring all the protein fragments in a drop of blood, has raised $28 million in a Series C round of financing….

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Sequenom Discloses 75 Layoffs as Part of Cost-Cutting Reorganization

Posted by sandiegobiotech August 19th, 2013 .
No Comments

San Diego-based Sequenom (NASDAQ: SQNM), which specializes in molecular diagnostics and genetic analysis, plans to lay off 75 employees, or nearly 13 percent of its workforce, as part of a…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Technology to Assess Neurons Gives New Life to San Diego’s Afraxis

Posted by sandiegobiotech August 19th, 2013 .
No Comments

San Diego’s Afraxis, which ceased to exist in January after the neuroscience startup licensed its entire library of drug compounds to Roche’s Genentech, has sprung back to life with proprietary…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Who Should Biotech Pros Follow on Twitter? An Update for 2013

Posted by sandiegobiotech August 19th, 2013 .
No Comments

[Updated: 12:07 pm PT] Twitter is where the biotech industry comes to trade news, analysis, and gossip every day. This has been true for a couple years. The 140-character blogging platform just keeps…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

Fate Therapeutics Joins Biotech IPO Conga Line, Reaching for $69M

Posted by sandiegobiotech August 14th, 2013 .
No Comments

San Diego-based Fate Therapeutics, the company that made a big splash a few years ago when it rounded up some big-name scientists with aspirations to do big things with stem cells, is the latest…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Sophiris, Isis, Qualcomm, & More

Posted by sandiegobiotech August 8th, 2013 .
No Comments

Another San Diego life sciences company is in line for an IPO, and the untimely death of Connect CEO Duane Roth has left a void in the leadership of San Diego’s innovation community. Here’s our…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

La Jolla Institute Extends 25-Year Partnership with Japanese Pharma

Posted by sandiegobiotech July 30th, 2013 .
No Comments

[Corrected 8/01/13, 00:30 am. See below.] The La Jolla Institute for Allergy and Immunology says it has extended its industry-academic collaboration with the California-based subsidiary of Kyowa…

[[Click headline to continue reading.]]

More...